StockData
Rallybio Corp logo

Rallybio Corp (RLYB) shareholders

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)

Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
12M of 5M shares
Institutional holders
37
9 new, 10 sold out
Net institutional buying
7M
In Q2 2026
Insider trades, 12 months
14 buys · 2 sales
Net bought $4.22M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Viking Global Opportunities Portfolio GP LLC
Joint filing with Viking Global Investors LP (9.99%), Viking Global Opportunities Parent GP LLC (9.99%) and 5 more
4,222,9699.99%13G (passive) amendmentDec 31, 2025
Pivotal bioVenture Partners Fund I, L.P.
Joint filing with Nan Fung Group Holdings Limited (6.40%), NF Investment Holdings Limited (6.40%) and 5 more
2,404,6446.40%13D (active) amendmentFeb 12, 2024
ADAR1 Capital Management, LLC
Joint filing with Daniel Schneeberger (17.50%)
926,35217.50%13G (passive)May 31, 2026
Abigail P. Johnson
Joint filing with FMR LLC (15.00%)
794,72015.00%13G (passive) amendmentJun 30, 2026
Viking Global Opportunities Parent GP LLC
Joint filing with Viking Global Investors LP (9.99%), Viking Global Opportunities GP LLC (9.99%) and 4 more
528,9549.99%13G (passive) amendmentMar 31, 2026
James G. Coulter
Joint filing with Tpg Gp A, LLC (7.20%), Jon Winkelried (7.20%)
378,5517.20%13D (active) amendmentMar 1, 2026
Dames GP LLC
Joint filing with Balyasny Asset Management L.P. (7.12%), Bam Gp LLC (7.12%) and 2 more
376,5737.12%13G (passive)Mar 31, 2026
Laurion Capital Management LP
Joint filing with Benjamin Alexander Smith (5.72%), Janaka Sheehan Maduraperuma (5.72%)
302,7565.72%13G (passive)Mar 31, 2026
Kush Parmar
Joint filing with Andrew J. Schwab (5.50%)
291,7885.50%13D (active) amendmentFeb 25, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of RLYBValueChange% of portfolio
Citadel Advisors LLC7,705,787143.13%$12.73M+7,685,9010.00%
ADAR1 Capital Management, LLC926,35217.21%$14.82M+905,8170.68%
FMR LLC794,72014.76%$12.72M+1,2690.00%
Viking Global Investors LP524,3479.74%$8.39M–0.02%
Tpg Gp A, LLC378,5517.03%$6.06M–0.12%
Nantahala Capital Management, LLC376,8447.00%$6.03M+76,2090.10%
Pivotal bioVenture Partners Investment Advisor LLC300,5795.58%$4.81M–1.56%
Renaissance Technologies LLC199,9073.71%$3.20M+43,3800.00%
Vanguard Capital Management LLC172,4973.20%$2.76M+60,4570.00%
Almitas Capital LLC120,6822.24%$1.93M−70,5240.46%
Rangeley Capital, LLC104,8501.95%$1.68M+74,7201.53%
Mariner, LLC50,5660.94%$809.06K–0.00%
Jane Street Group, LLC47,4230.88%$758.77KNew0.00%
Geode Capital Management, LLC32,0470.60%$512.87K−3,3780.00%
BlackRock, Inc.30,3320.56%$485.31K+12,8460.00%
Hrt Financial LP25,6570.48%$410.00KNew0.00%
XTX Topco Ltd21,4970.40%$343.95K+10,2710.00%
Vanguard Fiduciary Trust Co16,8200.31%$269.12K+3,2730.00%
Two Sigma Investments, LP16,6190.31%$265.90KNew0.00%
State Street Corp12,9960.24%$207.94KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20263712M100.0%9 / 106 / 109M2M
Q1 2026385M86.7%13 / 716 / 202M1M
Q4 2025463M57.9%4 / 711 / 20M0M
Q3 2025454M69.3%6 / 911 / 90M0M
Q2 2025484M72.4%7 / 812 / 60M0M
Q1 2025474M74.3%2 / 914 / 40M0M
Q4 2024494M75.3%7 / 1211 / 70M0M
Q3 2024494M72.5%2 / 1121 / 180M0M
Q2 2024664M73.4%21 / 1317 / 171M0M
Q1 2024624M70.5%13 / 1616 / 50M0M
Q4 2023544M74.0%9 / 2010 / 120M0M
Q3 2023584M72.4%5 / 1314 / 50M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

15 funds held RLYB in Q2 2026, 34% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of RLYBValue% of fundAs of
Fidelity Growth Company Fund207,6683.86%$3.00M0.00%May 31, 2026
Vanguard Total Stock Market Index Fund134,6202.50%$2.15M0.00%Jun 30, 2026
Fidelity Growth Company K6 Fund56,5221.05%$817.31K0.00%May 31, 2026
Fidelity Series Growth Company Fund53,6001.00%$775.06K0.00%May 31, 2026
Vanguard Extended Market Index Fund32,4470.60%$519.15K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund16,2520.30%$235.00K0.00%May 31, 2026
iShares Micro-Cap ETF11,8320.22%$189.31K0.01%Jun 30, 2026
Dimensional U.S. Small Cap ETF6,6750.12%$106.33K0.00%Jul 31, 2026
U.S. Micro Cap Portfolio4,6050.09%$73.36K0.00%Jul 31, 2026
Fidelity Series Total Market Index Fund4,5080.08%$65.19K0.00%May 31, 2026
Fidelity Total Market Index Fund4,0790.08%$58.98K0.00%May 31, 2026
Vanguard Institutional Total Stock Market Index Fund3,1410.06%$50.26K0.00%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund3,0030.06%$43.42K0.00%May 31, 2026
Vanguard Balanced Index Fund2,2890.04%$36.62K0.00%Jun 30, 2026
1290 VT Micro Cap Portfolio7950.01%$12.72K0.01%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Stephen UdenChief Executive Officer, Director148,8642.76%Oct 29, 2026
Jonathan I. LieberChief Financial Officer44,1390.82%Nov 3, 2026
Steven RyderChief Medical Officer192,3703.57%Feb 19, 2025
Ronald HuntDirector2,330,72843.29%Nov 5, 2026
Martin MackayDirector561,54910.43%Nov 5, 2026
Christine A. NashDirector3,5620.07%Oct 30, 2026
Wendy ChungDirector5,6240.10%Oct 28, 2026
Helen M. BoudreauDirector8,6040.16%Oct 20, 2026
Paula SoteropoulosDirector6,5440.12%Oct 20, 2026
Robert Lorne HopfnerDirector2,282,23142.39%Oct 14, 2026
Hui LiuDirector3,5620.07%Sep 28, 2026
ADAR1 Capital Management, LLC10% owner926,35217.21%May 20, 2026
Daniel Schneeberger10% owner909,94316.90%May 20, 2026
Llc Fmr10% owner211,7983.93%Mar 10, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ronald Hunt
Director
Nov 4, 2026Option exercise+14,305$4.45$63.66K29,125
Martin Mackay
Director
Nov 4, 2026Option exercise+18,055$4.45$80.34K125,032
Martin Mackay
Director
Nov 4, 2026Option exercise+3,562$2.38$8.48K106,977
Martin Mackay
Director
Nov 4, 2026Option exercise+11,607$7.60$88.21K103,415
Jonathan I. Lieber
Chief Financial Officer
Nov 2, 2026Option exercise+7,124$14.88$106.01K44,139
Jonathan I. Lieber
Chief Financial Officer
Oct 29, 2026Option exercise+13,589$6.08$82.62K37,015
Jonathan I. Lieber
Chief Financial Officer
Oct 29, 2026Option exercise+7,875$14.88$117.18K23,426
Ronald Hunt
Director
Oct 29, 2026Option exercise+2,062$15.28$31.51K14,820
Ronald Hunt
Director
Oct 29, 2026Option exercise+9,196$7.60$69.89K12,758
Ronald Hunt
Director
Oct 29, 2026Option exercise+3,562$2.38$8.48K3,562
Christine A. Nash
Director
Oct 28, 2026Option exercise+3,562$2.38$8.48K3,562
Stephen Uden
Chief Executive Officer, Director
Oct 27, 2026Option exercise+33,244$6.08$202.12K148,864
Jonathan I. Lieber
Chief Financial Officer
Oct 27, 2026Sale−599$16.04$9.61K15,551
Jonathan I. Lieber
Chief Financial Officer
Oct 26, 2026Award+2,500––16,150
Wendy Chung
Director
Oct 26, 2026Option exercise+2,062$15.28$31.51K5,624
Paula Soteropoulos
Director
Oct 16, 2026Option exercise+3,562$2.38$8.48K6,544
Helen M. Boudreau
Director
Oct 16, 2026Option exercise+2,062$15.28$31.51K8,604
Robert Lorne Hopfner
Director
Oct 12, 2026Option exercise+2,062$15.28$31.51K14,820
Robert Lorne Hopfner
Director
Oct 12, 2026Option exercise+3,562$2.38$8.48K12,758
Robert Lorne Hopfner
Director
Oct 12, 2026Option exercise+9,196$7.60$69.89K9,196
Jonathan I. Lieber
Chief Financial Officer
Oct 9, 2026Option exercise+3,910$6.08$23.77K13,650
Stephen Uden
Chief Executive Officer, Director
Oct 6, 2026Option exercise+22,456$6.08$136.53K115,620
Jonathan I. Lieber
Chief Financial Officer
Sep 29, 2026Option exercise+5,000$6.08$30.40K9,740
Hui Liu
Director
Sep 24, 2026Option exercise+3,562$2.38$8.48K3,562
Hui Liu
Director
Sep 24, 2026Option exercise+8,482$7.60$64.46K12,044
Wendy Chung
Director
Sep 16, 2026Option exercise+3,562$2.38$8.48K3,562
Helen M. Boudreau
Director
Jul 6, 2026Option exercise+3,562$2.38$8.48K6,542
ADAR1 Capital Management, LLC
10% owner
May 19, 2026Buy+200$13.80$2.76K926,352
ADAR1 Capital Management, LLC
10% owner
May 19, 2026Buy+10,000$13.98$139.80K926,152
ADAR1 Capital Management, LLC
10% owner
May 18, 2026Buy+6,009$13.98$84.01K916,152
Daniel Schneeberger
10% owner
May 15, 2026Buy+100$13.80$1.38K909,943
Daniel Schneeberger
10% owner
May 15, 2026Buy+200$13.95$2.79K910,143
Daniel Schneeberger
10% owner
May 13, 2026Buy+75,178$14.00$1.05M909,843
Daniel Schneeberger
10% owner
May 13, 2026Buy+4,081$13.80$56.32K834,665
ADAR1 Capital Management, LLC
10% owner
May 12, 2026Buy+800$13.83$11.06K830,584
ADAR1 Capital Management, LLC
10% owner
May 11, 2026Buy+19,900$14.00$278.60K829,784
ADAR1 Capital Management, LLC
10% owner
May 11, 2026Buy+5,100$14.00$71.40K784,884
ADAR1 Capital Management, LLC
10% owner
May 11, 2026Buy+25,000$14.00$350.00K809,884
Daniel Schneeberger
10% owner
May 5, 2026Buy+35,101$14.00$491.41K779,784
Daniel Schneeberger
10% owner
May 4, 2026Buy+116,904$13.97$1.63M744,683
Daniel Schneeberger
10% owner
May 4, 2026Buy+3,900$13.90$54.21K627,779
Jonathan I. Lieber
Chief Financial Officer
Feb 23, 2026Sale−789$5.06$3.99K4,115
Jonathan I. Lieber
Chief Financial Officer
Feb 18, 2026Award+2,500––4,904
Jonathan I. Lieber
See Remarks
Mar 14, 2023Buy+5,000$5.21$26.05K5,000
Kush Parmar
Director
Mar 7, 2023Sale−100,000$8.20$820.00K2,378,969
Andrew J. Schwab
10% owner
Mar 7, 2023Sale−100,000$8.20$820.00K2,378,969
Kush Parmar
Director, 10% owner
Jun 3, 2022Sale−50,329$12.50$629.11K1,251,755
Kush Parmar
Director, 10% owner
Jun 3, 2022Sale−99,671$12.50$1.25M2,478,969
5AM Partners V, LLC
10% owner
Jun 3, 2022Sale−99,671$12.50$1.25M2,478,969
5AM Partners V, LLC
10% owner
Jun 3, 2022Sale−50,329$12.50$629.11K1,251,755
5AM Partners V, LLC
10% owner
May 23, 2022Sale−66,447$13.00$863.81K2,578,640
5AM Partners V, LLC
10% owner
May 23, 2022Sale−33,553$13.00$436.19K1,302,084
Kush Parmar
Director, 10% owner
May 23, 2022Sale−33,553$13.00$436.19K1,302,084
Kush Parmar
Director, 10% owner
May 23, 2022Sale−66,447$13.00$863.81K2,578,640
Jeffrey M. Fryer
See Remarks
Mar 21, 2022Buy+3,000$8.04$24.12K47,048
Kush Parmar
Director
Feb 8, 2022Sale−70,461$13.05$919.52K1,335,637
Kush Parmar
Director
Feb 8, 2022Sale−139,539$13.05$1.82M2,645,087
5AM Ventures V, L.P.
10% owner
Feb 8, 2022Sale−70,461$13.05$919.52K1,335,637
5AM Ventures V, L.P.
10% owner
Feb 8, 2022Sale−139,539$13.05$1.82M2,645,087
Jeffrey M. Fryer
See Remarks
Jan 19, 2022Buy+1,400$8.70$12.18K44,048

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
2.65%
0M shares short
Days to cover
1.2
At 0M shares a day
Change since last report
-4.7%
From 0M shares
Short volume, 20 days
43.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Rallybio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,213 shares on Sep 2, 2026 over the last 90 days.

See a number that looks wrong?